S2 Ep3: Bridging the AI Enthusiasm Gap

Most life science teams are stuck talking about AI transformation while competitors execute it. The gap between 68% AI optimism and 7% power users isn't about awareness - it's about execution.

This episode is for biotech marketers and product managers navigating AI adoption and product development decisions. Matt and Jasmine explore why organisations retire risk by standardising rather than solving creatively - a pattern that undermines both AI implementation and product differentiation. The key insight: AI makes it dangerously easy to produce more without asking if the strategy underneath is broken. The winners use AI to do better, not just more.

What you will learn:

• Why "secret cyborgs" using free AI tools with zero guardrails are a symptom of execution failure
• How to move personas from static PDFs to interactive synthetic customers you can query
• When to pause AI implementation because you're optimising the wrong work
• Why Stage Gate committees systematically prune differentiation before launch
• How product managers can defend customer pain points with veto authority
• The connection between AI pilot mode and launching commoditised products

Keywords: AI implementation life science, synthetic customer persona, AI execution gap, Stage Gate product development, biotech marketing strategy, AI guardrails, product differentiation, crossing the chasm life science, voice of customer, AI literacy

Watch the full episode, subscribe for weekly insights, and visit strivenn.com for tools to close your own execution gaps.